Literature DB >> 926716

The diagnostical significance of antibodies against hepatitis B core antigen.

W H Gerlich, R M Biswas, B Stamm, R Thomssen.   

Abstract

The frequency of hepatitis B was examined using three serological parameters: HBsAg, antiHBs and antiHBc. All three substances were detected qualitatively by means of sensitive radioimmunological techniques. Of 1216 patients with acute hepatitis, 55 percent were HBsAg and antiHBc positive on admission to hospital. A further 17.8 percent had no HBsAg but were antiHBc positive and also partly antiHBs positive. These cases can be divided into 2 groups: In one group, in 8.6 percent of patients had a high antiHBc concentration during the acute phase. Similar antiHBc concentrations were seldom found (0.04 percent) in HBsAg negative blood donors. AntiHBs in the patients was at first mainly negative and then appeared during reconvalescence. These cases were considered to be acute hepatitis type B, although HBsAg was absent. In the second group, comprising 9.2 percent of the patients, antiHBc was present in low concentrations and in majority of cases antiHBs had been present from the beginning. The same antibody constellation was found in 3.6 percent of 2341 blood donors. In the group of patients it is supposed that the acute hepatitis present is not of type B and has a different aetiology. The low concentration of antibody is interpreted to be a sign of an earlier HBV-infection.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 926716     DOI: 10.1007/bf01489479

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  Determination of antibody to hepatitis B core antigen by means of immune adherence hemagglutination.

Authors:  F Tsuda; T Takahashi; K Takahashi; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

2.  [Preliminary report on the cooperative DFG study "Acute viral hepatitis"].

Authors:  U Kaboth; M Alexander; H Beckenbach; M Brodersen; O Brückner; L Brügmann; W Creutzfeldt; H Deicher; W Gerlich; M Grün; I Grünert-Fuchs; K Havemann; T H Hütteroth; H Immich; O Klinge; J Knolle; G A Martini; C Mascher; K H Meyer zum Büschenfelde; R Müller; R Nowrousian; H Ortmans; R Sanwald; M Sattel; A Schober; H Schultz; C P Sodomann; B Stamm; G Thamer; R Thomssen; W Wepler; G Wille
Journal:  Verh Dtsch Ges Inn Med       Date:  1976

3.  Detection of antibody to hepatitis Bs-antigen in patients with acute and chronic hepatitis as measured by a modified procedure of the radioimmunoassay Ausria I 125.

Authors:  R Müller; B Stephan; R Kramer; H Deicher
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

4.  [Etiology of hepatitis B. Preliminary results of a cooperative study (proceedings)].

Authors:  R Thomssen; W Gerlich; B Stamm; R Biswas; P R Lorenz; M Majer; E Weinmann; W Arnold; G Hess; W Wepler; O Klinge
Journal:  Zentralbl Bakteriol Orig A       Date:  1976-08

5.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

6.  Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen.

Authors:  S Krugman; J H Hoofnagle; R J Gerety; P M Kaplan; J L Gerin
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

7.  Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.

Authors:  J H Hoofnagle; R J Gerety; L Y Ni; L F Barker
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

8.  Quantitative standardization in the detection of hepatitis B surface antigen: results of a collaborative study involving 74 laboratories.

Authors:  W Gerlich; B Stamm; R Thomssen
Journal:  J Biol Stand       Date:  1976

9.  New antigen-antibody system in Australia-antigen-positive hepatitis.

Authors:  J D Almeida; D Rubenstein; E J Stott
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

10.  Direct solid-phase radioimmunoassay (dSP-RIA) for detection of antibody to hepatitis B surface (HBs) antigen.

Authors:  A Schober; R M Biswas; R Thomssen
Journal:  Dev Biol Stand       Date:  1975
View more
  4 in total

1.  Radioimmunoassay for LCM virus antigens and anti-LCM virus antibodies and its application in an epidemiologic survey of people exposed to syrian hamsters.

Authors:  M Blechschmidt; W Gerlich; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1977-05-18       Impact factor: 3.402

2.  Frequent detection of antibodies to hepatitis B virus x-protein in acute, chronic and resolved infections.

Authors:  J Hess; M Stemler; H Will; C H Schröder; J Kühn; R Braun
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

3.  Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections.

Authors:  W H Gerlich; A Uy; F Lambrecht; R Thomssen
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

4.  Direct radioimmunoassay of antibody against hepatitis B core antigen using 32P-labelled core particles.

Authors:  W Wolff; W H Gerlich
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.